Abstract
Introduction: In this mini review we analized some cases of Ovarian Lymphoma (OL) offprint from the previous literature, both primary and secondary. Discussion: We know that a standard method of staging and follow-up in non-Hodgkin's lymphomas is PET/CT, which, however, due to the limited presence of ovarian lymphomas in the population, is not present in the literature as a primary tool in the diagnosis of this type of neoplasm. The first suspected dignosis is often done with US, CT or MRI, but the gold standard remains the biopsy. As regards for the chemotheraphy those cases poin out the non-toxicity of rituximab and its possible routinary use in the treatment of OL. Conclusion: US, CT and MRI are the first diagnostic tools in the diagnosis of OL. Nowadays PET/CT is used in the staging and follow-up of OL. The R-CHOP protocol can be utilized in the treatment of OL, reducing the use of readioteraphy. Gynecologists must be aware of this rare ovarian tumor in order to avoid unnecessary radical surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Biomedical Research & Environmental Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
